Daewoong Pharmaceutical "ITC Preliminary Decision to Ban Imports for 10 Years Due to Trade Secret Infringement"

[Asia Economy Reporter Yoo Byung-don] Daewoong Pharmaceutical announced on the 7th that it has confirmed the preliminary decision regarding the case filed last year by Medytox and Allergan with the U.S. International Trade Commission (ITC) concerning trade secret infringement.

The company stated, "In the preliminary decision, the ITC administrative law judge recommended, without binding effect, a 10-year import ban order, finding that Daewoong Pharmaceutical infringed Medytox's trade secrets." It added, "Since the ITC final ruling is scheduled for November this year, we will actively present our arguments in the final decision."